Vedolizumab-4024: A Multi-center, Longitudinal, Observational Study of the Effectiveness of Vedolizumab on Clinical Outcomes and Health-Related Quality if Life in Biologic Naive Patients with Inflammatory Bowel Diseases in Serbia Over a 2-year Period